Podcast: Wellness chatbots and meditation pods with Deepak Chopra

Podcast: Wellness chatbots and meditation pods with Deepak Chopra

Leaps.org talked with Deepak Chopra about new technologies he's developing for mental health with Jonathan Marcoschamer, CEO of OpenSeed, and others.

Hannah Cohen

Over the last few decades, perhaps no one has impacted healthy lifestyles more than Deepak Chopra. While several of his theories and recommendations have been criticized by prominent members of the scientific community, he has helped bring meditation, yoga and other practices for well-being into the mainstream in ways that benefit the health of vast numbers of people every day. His work has led many to accept new ways of thinking about alternative medicine, the power of mind over body, and the malleability of the aging process.

His impact is such that it's been observed our culture no longer recognizes him as a human being but as a pervasive symbol of new-agey personal health and spiritual growth. Last week, I had a chance to confirm that Chopra is, in fact, a human being – and deserving of his icon status – when I talked with him for the Leaps.org podcast. He relayed ideas that were wise and ancient, yet highly relevant to our world today, with the fluidity and ease of someone discussing the weather. Showing no signs of slowing down at age 76, he described his prolific work, including the publication of two books in the past year and a range of technologies he’s developing, including a meditation app, meditation pods for the workplace, and a chatbot for mental health called Piwi.

Take a listen and get inspired to do some meditation and deep thinking on the future of health. As Chopra told me, “If you don’t have time to meditate once per day, you probably need to meditate twice per day.”


Highlights:

2:10: Chopra talks about meditation broadly and meditation pods, including the ones made by OpenSeed for meditation in the workplace.
6:10: The drawbacks of quick fixes like drugs for mental health.
10:30: The benefits of group meditation versus individual meditation.
14:35: What is a "metahuman" and how to become one.
19:40: The difference between the conditioned mind and the mind that's infinitely creative.
22:48: How Chopra's views of free will differ from the views of many neuroscientists.
28:04: Thinking Fast and Slow, and the role of intuition.
31:20: Athletic and creative geniuses.
32:43: The nature of fundamental truth.
34:00: Meditation for kids.
37:12: Never alone.Love and how AI chatbots can support mental health.
42:30: Extending lifespan, gene editing and lifestyle.
46:05: Chopra's mentor in living a long good life (and my mentor).
47:45: The power of yoga.

Links:

- OpenSeed meditation pods for people to meditate at work (Chopra is an advisor to OpenSeed).
- Chopra's book from 2021, Metahuman: Unleash Your Infinite Potential
- Chopra's book from 2022, Abundance: The Inner Path to Wealth
- NeverAlone.Love, Chopra's collaboration of businesses, policy makers, mental health professionals and others to raise awareness about mental health, advance scientific research and "create a global technology platform to democratize access to resources."
- The Piwi chatbot for mental health
- The Chopra Meditation & Well-Being App for people of all ages
- Only 1.6 percent of U.S. children meditate, according to the National Center for Complementary and Integrative Health

Matt Fuchs
Matt Fuchs is the host of the Making Sense of Science podcast and served previously as the editor-in-chief of Leaps.org. He writes as a contributor to the Washington Post, and his articles have also appeared in the New York Times, WIRED, Nautilus Magazine, Fortune Magazine and TIME Magazine. Follow him @fuchswriter.
Opioid prescription policies may hurt those in chronic pain

Guidelines aim to prevent opioid-related deaths by making it more challenging to get prescriptions, but they can also block access for those who desperately need them.

Adobe Stock

Tinu Abayomi-Paul works as a writer and activist, plus one unwanted job: Trying to fill her opioid prescription. She says that some pharmacists laugh and tell her that no one needs the amount of pain medication that she is seeking. Another pharmacist near her home in Venus, Tex., refused to fill more than seven days of a 30-day prescription.

To get a new prescription—partially filled opioid prescriptions can’t be dispensed later—Abayomi-Paul needed to return to her doctor’s office. But without her medication, she was having too much pain to travel there, much less return to the pharmacy. She rationed out the pills over several weeks, an agonizing compromise that left her unable to work, interact with her children, sleep restfully, or leave the house. “Don’t I deserve to do more than survive?” she says.

Keep Reading Keep Reading
Robin Donovan
Robin Donovan is a science journalist based in Portland, Oregon. Her work has appeared in Vice, Neo.Life, The Scientist, Willamette Week and many other outlets.
Immigrant Scientists—and America’s Edge—Face a Moment of Truth This Election

Recent immigration restrictions have left many foreign researchers' projects and careers in limbo—and some in jeopardy.

Unsplash

This article is part of the magazine, "The Future of Science In America: The Election Issue," co-published by LeapsMag, the Aspen Institute Science & Society Program, and GOOD.

When COVID-19 cases were surging in New York City in early spring, Chitra Mohan, a postdoctoral fellow at Weill Cornell, was overwhelmed with worry. But the pandemic was only part of her anxieties. Having come to the United States from India on a student visa that allowed her to work for a year after completing her degree, she had applied for a two-year extension, typically granted for those in STEM fields. But due to a clerical error—Mohan used an electronic signatureinstead of a handwritten one— her application was denied and she could no longerwork in the United States.

"I was put on unpaid leave and I lost my apartment and my health insurance—and that was in the middle of COVID!" she says.

Meanwhile her skills were very much needed in those unprecedented times. A molecular biologist studying how DNA can repair itself, Mohan was trained in reverse transcription polymerase chain reaction or RT-PCR—a lab technique that detects pathogens and is used to diagnose COVID-19. Mohan wanted to volunteer at testing centers, but because she couldn't legally work in the U.S., she wasn't allowed to help either. She moved to her cousin's house, hired a lawyer, and tried to restore her work status.

Keep Reading Keep Reading
Lina Zeldovich

Lina Zeldovich has written about science, medicine and technology for Popular Science, Smithsonian, National Geographic, Scientific American, Reader’s Digest, the New York Times and other major national and international publications. A Columbia J-School alumna, she has won several awards for her stories, including the ASJA Crisis Coverage Award for Covid reporting, and has been a contributing editor at Nautilus Magazine. In 2021, Zeldovich released her first book, The Other Dark Matter, published by the University of Chicago Press, about the science and business of turning waste into wealth and health. You can find her on http://linazeldovich.com/ and @linazeldovich.